Outpatient Management of COVID-19: A Primer for the Dermatologist.

ABSTRACT:

Purpose of review

To summarize diagnostic and therapeutic management of COVID-19 in the outpatient setting for dermatologists.

Recent findings

Paxlovid (nirmatrelvir-ritonavir) is the preferred treatment in patients with mild symptoms at high risk of progression to severe SARS-CoV2 infection. Additional options include monoclonal antibodies (bebtelovimab), remdesivir, and molnupiravir.

Summary

Dermatologists need to be aware of recent developments in diagnostic and therapeutic management of COVID-19 in the outpatient setting, as their patients may rely on dermatologists to provide advice, particularly in cases where treatments for dermatological disease may impact the risk of COVID-19 and/or vaccine efficacy.

Supplementary information

The online version contain

SUBMITTER: Wang S 

PROVIDER: S-EPMC9391204 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature